Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
137M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
9.36M
-
Shares change
-
+6.06M
-
Total reported value, excl. options
-
$13.9M
-
Value change
-
+$9.08M
-
Number of buys
-
29
-
Number of sells
-
-12
-
Price
-
$1.49
Significant Holders of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) as of Q1 2025
50 filings reported holding LUCD - Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share as of Q1 2025.
Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.36M shares
of 137M outstanding shares and own 6.83% of the company stock.
Largest 10 shareholders include MASTERS CAPITAL MANAGEMENT LLC (2.73M shares), Alyeska Investment Group, L.P. (1.89M shares), VANGUARD GROUP INC (889K shares), RENAISSANCE TECHNOLOGIES LLC (459K shares), LUMINUS MANAGEMENT LLC (457K shares), Ghisallo Capital Management LLC (422K shares), Sunbelt Securities, Inc. (384K shares), Lido Advisors, LLC (383K shares), GEODE CAPITAL MANAGEMENT, LLC (303K shares), and MILLENNIUM MANAGEMENT LLC (204K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.